ARTICLE | Product Development
ESA timeline
March 12, 2007 7:00 AM UTC
In May 2004, FDA's Oncologic Drugs Advisory Committee concluded that ongoing trials sponsored by Amgen (AMGN) and Johnson & Johnson (JNJ) were likely to address safety concerns about the use of erythr...